title: [Blockade of the PDGF receptor: a new and effective therapy option for NPM-ALK-dependent lymphoma].
authors.affiliation: Medizinische Universität Wien, Spitalgasse 23, 1090, Wien, Österreich, daniela.laimer@meduniwien.ac.at.
authors.forename: D
authors.initials: D
authors.lastname: Laimer-Gruber
mesh_terms: D000293:Adolescent; D000328:Adult; D000818:Animals; D001549:Benzamides / Q000009:adverse effects / Q000627:therapeutic use*; D002648:Child; D006801:Humans; D000068877:Imatinib Mesylate; D008198:Lymph Nodes / Q000473:pathology; D017728:Lymphoma, Large-Cell, Anaplastic / Q000188:drug therapy* / Q000235:genetics* / Q000378:metabolism / Q000473:pathology; D051379:Mice; D064847:Multimodal Imaging; D010879:Piperazines / Q000009:adverse effects / Q000627:therapeutic use*; D049268:Positron-Emission Tomography; D011505:Protein-Tyrosine Kinases / Q000235:genetics*; D011743:Pyrimidines / Q000009:adverse effects / Q000627:therapeutic use*; D017479:Receptors, Platelet-Derived Growth Factor / Q000037:antagonists & inhibitors*; D014057:Tomography, X-Ray Computed; D055815:Young Adult
chemical_list: D001549:Benzamides; D010879:Piperazines; D011743:Pyrimidines; D000068877:Imatinib Mesylate; C107023:p80(NPM-ALK) protein; D011505:Protein-Tyrosine Kinases; D017479:Receptors, Platelet-Derived Growth Factor